Cimzia (certolizumab pegol) Lyophilized Powder and Solution for Subcutaneous Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
WARNINGS AND PRECAUTIONS
Risk of Serious Infections
Tuberculosis
Treatment of latent tuberculosis infection...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts